Quantitation of Glymphatic Functioning in Sleep and Meditative States

Purpose

This involves development and application of magnetic resonance imaging (MRI) methods for visualizing hemodynamic and metabolic relationships in healthy volunteers with advanced meditation experience.

Conditions

  • Parkinson Disease
  • Sleep

Eligibility

Eligible Ages
Between 18 Years and 45 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Ages 14-45 - "Adept meditator status"

Exclusion Criteria

  • Any non-MR compatible material implant, or contraindication to MR scanning - Claustrophobia or inability to lie still for prolonged periods of time - Participants with a recent (less than 2 months) infection, tattoo, or wound - No consumption of stimulants or alcohol within 12 hours of the study visit - clinical diagnosis of any major neurological or psychological condition - Taking benzodiazepines, cholinestorase inhibitors, anti-psychotics, opioids, MAO inhibitors

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)
Masking Description
no masking is used in this protocol

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Adept Meditators
Subjects will undergo scanning during awake, sleep deprived, and meditative states of consciousness.
  • Behavioral: Meditation
    meditation

Recruiting Locations

Vanderbilt University Medical Center
Nashville, Tennessee 37212-3160

More Details

Status
Recruiting
Sponsor
Vanderbilt University Medical Center

Study Contact

Daniel Claassen, MD
6153226103
daniel.claassen@vumc.org

Detailed Description

This study is evaluating the glymphatic system during awake, sleep, and meditative states.